Molimo pogledajte kompletan savjet za više informacija, uključujući šta bi Kanađani trebali učiniti i rad Health Canada na rješavanju problema azido nečistoća koje se nalaze u određenim lijekovima.
| Proizvod | Kompanija | IZ | mnogo | Istek |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389657 | 2005006959 | April 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389657 | 2005006960 | April 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389657 | 2005006961 | April 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389657 | 2005006962 | April 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389657 | 2005006963 | April 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389657 | 2005011154 | Juni 2023 |
| MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389657 | 2005011156 | Juni 2023 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389665 | 2005006807 | April 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389665 | 2005006808 | April 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389665 | 2005006809 | April 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389665 | 2005006810 | April 2022 |
| MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETE | Mint Pharmaceuticals Inc. | 02389665 | 2105002149 | Decembar 2022 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 1805012687 | Oktobar 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 1805012688 | Oktobar 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 1805012689 | Oktobar 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 1805012792 | Oktobar 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 1905001010 | Decembar 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 1905001011 | Decembar 2021 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 2005006947 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 2005006949 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 2005006950 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 2005006951 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 2005007297 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 2005007298 | April 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 2005013776 | avgust 2023 |
| MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE | Mint Pharmaceuticals Inc. | 02389673 | 2105002150 | Decembar 2023 |
ŠTA UZIMATI IZ OVOG ČLANKA:
- 023896732005006947April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE Mint Pharmaceuticals Inc.
- 023896732005006949April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE Mint Pharmaceuticals Inc.
- 023896732005006950April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETE Mint Pharmaceuticals Inc.
